2024年

• 1: Wakisaka K, Matsuo R, Irie F, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators.
  Association between abdominal adiposity and clinical outcomes in patients with acute ischemic stroke.
  PLoS One. 2024 Jan 11;19(1):e0296833. doi: 10.1371/journal.pone.0296833. PMID: 38206990; PMCID: PMC10783725.
• 2: Jamal A, Babazono A, Liu N, Yamao R, Fujita T, Kim SA, Li Y.
  Associating Liver Enzymes and Their Interactions with Metabolic Syndrome Prevalence in a Japanese Working Population.
  Metab Syndr Relat Disord. 2024 Feb;22(1):27-38. doi: 10.1089/met.2023.0055. Epub 2023 Nov 14. PMID: 38350086.
• 3: Kim SA, Maeda M, Murata F, Fujii T, Ueda E, Ono R, Fukuda H.
  Impact of Concurrent Visual and Hearing Impairment on Incident Alzheimer’s Disease: The LIFE Study.
  J Alzheimers Dis. 2024 Feb 14. doi: 10.3233/JAD-230806. Epub ahead of print. PMID: 38363608.
• 4: Mezuki S, Matsuo R, Irie F, Shono Y, Kuwashiro T, Sugimori H, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators.
  Body temperature in the acute phase and clinical outcomes after acute ischemic stroke.
  PLoS One. 2024 Jan 11;19(1):e0296639. doi: 10.1371/journal.pone.0296639. PMID: 38206979; PMCID: PMC10783745.
• 5: Li Y, Babazono A, Jamal A, Liu N, Liang L, Yamao R, Zhao R, Yao L.
  Effect of the national lifestyle guidance intervention for metabolic syndrome among middle-aged people in Japan.
  J Glob Health. 2024 Feb 9;14:04007. doi: 10.7189/jogh.14.04007. PMID: 38334270; PMCID: PMC10854208.
• 6: Murata F, Maeda M, Murayama K, Nakao T, Fukuda H.
  Associations between COVID-19 vaccination and incident psychiatric disorders after breakthrough SARS- CoV-2 infection: The VENUS Study.
  Brain Behav Immun. 2024 Mar;117:521-528. doi: 10.1016/j.bbi.2024.02.018. Epub 2024 Feb 12. PMID: 38355026.
• 7: Liu N, Babazono A, Jamal A, Yoshida S, Yamao R, Ishihara R, Matsuda S, Li Y.
  Impact of fee-revision policy for gastrostomy on its implementation among older adults with dementia in Japan.
  Public Health. 2024 Feb;227:63-69. doi: 10.1016/j.puhe.2023.11.032. Epub 2023 Dec 20. PMID: 38118244.
• 8: Maeda M, Murata F, Fukuda H.
  The age-specific impact of COVID-19 vaccination on medical expenditures and hospitalization duration after breakthrough infection: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) Study.
  Vaccine. 2024 Feb 5:S0264-410X(24)00106-3. doi: 10.1016/j.vaccine.2024.01.082. Epub ahead of print. PMID: 38320932.
• 9: Yamao R, Babazono A, Liu N, Li Y, Ishihara R, Yoshida S, Kim SA, Jamal A.
  The Impact of Continuous Use of Home Health Care Resources on End-of-Life Care at Home in Older Patients with Cancer: A Retrospective Cohort Study in Fukuoka, Japan.
  Popul Health Manag. 2024 Feb;27(1):60-69. doi: 10.1089/pop.2023.0192. Epub 2023 Nov 1. PMID: 37910804.
• 10: Tamada Y, Takeuchi K, Kusama T, Maeda M, Murata F, Osaka K, Fukuda H.
  Bivalent mRNA vaccine effectiveness against COVID-19 among older adults in Japan: a test-negative study from the VENUS study.
  BMC Infect Dis. 2024 Jan 29;24(1):135. doi: 10.1186/s12879-024-09035-3. PMID: 38287337; PMCID: PMC10823731.
• 11: Yoshizato R, Motomura Y, Fujita T, Babazono A, Ohga S.
  Secondhand smoking and pediatric asthma after respiratory syncytial virus or human metapneumovirus infection.
  Ann Allergy Asthma Immunol. 2024 Feb;132(2):240-242. doi: 10.1016/j.anai.2023.10.013. Epub 2023 Oct 18. PMID: 37863190.
• 12: Sato S, Kawazoe Y, Katsuta T, Fukuda H.
  Comparison design and evaluation power in cohort and self-controlled case series designs for post-authorization vaccine safety studies.
  PeerJ. 2024 Jan 23;12:e16780. doi: 10.7717/peerj.16780. PMID: 38282861; PMCID: PMC10812582.
• 13: Murata F, Maeda M, Ono R, Fukuda H.
  Association between regular physical activity and pneumonia-related hospitalization according to pneumococcal vaccination status: The VENUS study.
  Vaccine. 2024 Feb 27;42(6):1268-1274. doi: 10.1016/j.vaccine.2024.01.060. Epub 2024 Jan 28. PMID: 38281899.
• 14: Sagara K, Goto K, Maeda M, Murata F, Fukuda H.
  Medication adherence and associated factors in newly diagnosed hypertensive patients in Japan: the life study.
  J Hypertens. 2024 Jan 18. doi: 10.1097/HJH.0000000000003661. Epub ahead of print. PMID: 38230627.
• 15: Miyano T, Ayukawa Y, Anada T, Takahashi I, Furuhashi H, Tokunaga S, Hirata A, Nakashima N, Kato K, Fukuda H.
  Association Between Reduced Posterior Occlusal Contact and Alzheimer’s Disease Onset in Older Japanese Adults: Results from the LIFE Study.
  J Alzheimers Dis. 2024;97(2):871-881. doi: 10.3233/JAD-230449. PMID: 38160352; PMCID: PMC10894584.
• 16: Yamada N, Nakatsuka K, Tezuka M, Murata F, Maeda M, Akisue T, Fukuda H, Ono R.
  Pneumococcal vaccination coverage and vaccination-related factors among older adults in Japan: LIFE Study.
  Vaccine. 2024 Jan 12;42(2):239-245. doi: 10.1016/j.vaccine.2023.12.009. Epub 2023 Dec 11. PMID: 38087713.
• 17: Sato S, Katsuta T, Kawazoe Y, Takahashi M, Murata F, Maeda M, Fukuda H, Kamidani S.
  Immune thrombocytopenic purpura and Guillain-Barré syndrome after 23-valent pneumococcal polysaccharide vaccination in Japan: The vaccine effectiveness, networking, and universal safety (VENUS) study.
  Vaccine. 2024 Jan 1;42(1):4-7. doi: 10.1016/j.vaccine.2023.11.053. Epub 2023 Dec 2. PMID: 38044244.
• 18: Moriyama S, Hieda M, Kisanuki M, Kawano S, Yokoyama T, Fukata M, Kusaba H, Maruyama T, Baba E, Akashi K, Fukuda H.
  Both New-Onset and Pre-Existing Hypertension Indicate Favorable Clinical Outcomes in Patients Treated With Anti- Vascular Endothelial Growth Factor Therapy.
  Circ J. 2024 Jan 25;88(2):217-225. doi: 10.1253/circj.CJ-22-0628. Epub 2022 Dec 6. PMID: 36476830.